Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOBILE
CTR20254954Phase 3Active
- Sponsor
- MindRank
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of MDR-001 in obesity, Overweight, sponsored by MindRank. Started Feb 2026; status: active.
02
Drugs
MDR-001
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20254954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254954.